News for 'Drug Administration'

Booster dose of anti-Covid vax not needed at this stage: Experts

Booster dose of anti-Covid vax not needed at this stage: Experts

Rediff.com18 Sep 2021

As the global debate on booster shots gathers momentum, several scientists in New Delhi said the priority must be to ensure that more people are inoculated with at least their first jab.

Oxford Covid vaccine under lens after error: Report

Oxford Covid vaccine under lens after error: Report

Rediff.com26 Nov 2020

AstraZeneca Plc and the University of Oxford are facing questions about their Covid-19 vaccine and whether regulators would quickly authorise its emergency use after the pharma company acknowledged an error in the vaccine dosage received by some participants and other irregularities and omissions, according to the New York Times.

Coronavirus crisis could stretch up to August, warns Trump

Coronavirus crisis could stretch up to August, warns Trump

Rediff.com17 Mar 2020

At least 85 people have died of coronavirus with the confirmed cases crossing 4,500 in the US.

Piramal Enterprises to stop early-stage research

Piramal Enterprises to stop early-stage research

Rediff.com28 Aug 2014

To focus on molecules at advanced stage of development; move to impact 200 scientists.

Why India's pharma cos prefer Gujarat over tax havens

Why India's pharma cos prefer Gujarat over tax havens

Rediff.com23 Sep 2017

Gujarat has around 3,000 licensees for allopathic drug manufacturing, apart from around seven homeopathic licensees, 500 ayuvedic and 600-700 cosmetics licensees

As India records 2.34 lakh Covid cases, PM urges: Test, track, treat

As India records 2.34 lakh Covid cases, PM urges: Test, track, treat

Rediff.com17 Apr 2021

Top officers across various ministries participate in the meeting that started at 8 pm on Saturday. The meeting is currently underway. The country is currently witnessing a second and more severe wave of the pandemic.

Fadnavis gets home, finance; BJP bags key portfolios in Maha cabinet

Fadnavis gets home, finance; BJP bags key portfolios in Maha cabinet

Rediff.com14 Aug 2022

Five days after the induction of 18 ministers into his cabinet, Maharashtra Chief Minister Eknath Shinde on Sunday allocated portfolios, keeping Urban Development and 11 other ministries with himself, while giving the crucial Home Department to Deputy CM Devendra Fadnavis.

How safe are cheap medicines made in India?

How safe are cheap medicines made in India?

Rediff.com11 Mar 2016

An International Policy Network report in 2010 found that seven per cent of drugs bought from wholesale traders were substandard, and 3.6 per cent of the drugs from traders contained no active ingredient whatsoever.

Top US doctor cautiously optimistic over COVID vaccine

Top US doctor cautiously optimistic over COVID vaccine

Rediff.com9 Jul 2020

There are a number of vaccine candidates already in clinical trial and a few out of those candidates have completed phase 1/2 status, he said, adding that there are trials that will be going into phase three sometime at the end of July and then others will follow in the months of August, September and October.

Sensex retreats from 6-week high, slides 253 points

Sensex retreats from 6-week high, slides 253 points

Rediff.com15 Mar 2016

Of the 30-share Sensex pack, 22 ended with losses while NTPC ended flat at Rs 127.30.

India readies for massive testing exercise after lockdown

India readies for massive testing exercise after lockdown

Rediff.com28 Mar 2020

The ICMR is working on a war footing to develop the testing ecosystem -- especially for the screening blood tests. NIV, Pune, is in the process of validating antibody-based screening kits.

Sun-Ranbaxy merger may spill over to 2015

Sun-Ranbaxy merger may spill over to 2015

Rediff.com15 Nov 2014

The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.

Ranbaxy buy in line with Sun's strategy

Ranbaxy buy in line with Sun's strategy

Rediff.com17 Apr 2014

The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.

Oxford vaccine doing 'everything expected': Study

Oxford vaccine doing 'everything expected': Study

Rediff.com22 Oct 2020

A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.

2 policemen among 5 J-K govt employees sacked for terror links

2 policemen among 5 J-K govt employees sacked for terror links

Rediff.com30 Mar 2022

The Jammu and Kashmir administration on Wednesday sacked police constable Tawseef Ahmed Mir, who has been accused of actively working for Hizbul Mujahideen and trying to kill two of his colleagues, and four more employees for alleged links with terror groups.

Sensex, Nifty end in the red

Sensex, Nifty end in the red

Rediff.com16 Jun 2017

Pharma was the top losing index amid worries about their earnings outlook with Lupin down over 4%

Anti-doping bill introduced in Lok Sabha

Anti-doping bill introduced in Lok Sabha

Rediff.com17 Dec 2021

Many federations and former athletes alike have been calling for an anti-doping legislation to implement the existing rules.

S-400 missiles very important for Indian defence capability: Lavrov

S-400 missiles very important for Indian defence capability: Lavrov

Rediff.com6 Dec 2021

"The deal is being implemented. We witnessed attempts on the part of the US to undermine this cooperation and make India obey the American orders to follow the American vision of how this region should be developed," Russian Foreign Minister Sergey Lavrov said.

Declare 'black fungus' as notifiable disease: Centre to states

Declare 'black fungus' as notifiable disease: Centre to states

Rediff.com21 May 2021

As cases of 'black fungus' among COVID-19 patients in the country rise to cross 7,000, the Centre on Thursday urged all states and union territories to declare it as a notifiable disease under the Epidemic Diseases Act to ensure mandatory surveillance to tackle the 'new challenge'.

'50 to 60 crore across India would be infected'

'50 to 60 crore across India would be infected'

Rediff.com20 May 2021

'At least half the population in UP has been infected.'

UK health regulator withdraws nod for another Wockhardt unit

UK health regulator withdraws nod for another Wockhardt unit

Rediff.com22 Oct 2013

The company has received a communication from the Medicines and Healthcare Products Regulatory Agency, United Kingdom, whereby the agency has decided to withdraw the previously issued GMP Certificate to the company's manufacturing facility situated at Kadaiya, Nani Daman, Wockhardt said in a filing to the Bombay Stock Exchange.

ICMR to conduct nationwide sero surveys on Covid spread

ICMR to conduct nationwide sero surveys on Covid spread

Rediff.com12 Jun 2021

The Indian Council of Medical Research will start national-level sero surveys to assess the spread of Covid-19 and all states/Union territories should also be encouraged to conduct them so that information from all geographies can be collected, the Union health ministry said on Friday.

'US FDA not on a witch hunt against India pharma firms'

'US FDA not on a witch hunt against India pharma firms'

Rediff.com23 Sep 2013

This is not just a Ranbaxy or Wockhardt problem, says K Satish Reddy

Wockhardt medicines banned in Europe

Wockhardt medicines banned in Europe

Rediff.com11 Jul 2013

Its Waluj manufacturing facility in Maharashtra failed to meet the good manufacturing norms prescribed by the UK drug regulator.

Indian pharma cos shifting R&D to SE Asian countries

Indian pharma cos shifting R&D to SE Asian countries

Rediff.com4 Jul 2013

South-east Asian countries are emerging as preferable destination for India's pharma companies to expand their business as they share similar patient population and disease profile and moreover, have a conducive environment for their operations like easy market approach without any regulatory uncertainty, the survey of Indian pharma firms highlighted.

Allocation of Remdesivir has to be need-based: HC to Centre, Maha govt

Allocation of Remdesivir has to be need-based: HC to Centre, Maha govt

Rediff.com19 Apr 2021

The court directed the Union and the Maha governments to file their affidavits by April 21, pointing out the parameters followed for the regulation and distribution of Remdesivir vials.

Sensex ends flat after hitting life-time high of 28,283

Sensex ends flat after hitting life-time high of 28,283

Rediff.com18 Nov 2014

Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.

COVID-19: Rajnath asks armed forces to help states

COVID-19: Rajnath asks armed forces to help states

Rediff.com20 Apr 2021

It was decided that the senior-most Army officer in a state would get in touch with the chief minister to understand the requirement and take forward the process, including offering to treat civilians wherever possible

Profit might be hit in FY16: Sun Pharma

Profit might be hit in FY16: Sun Pharma

Rediff.com21 Jul 2015

4 Ranbaxy facilities in India have been barred from exporting to US.

US allows 'game-changer' saliva-based Covid test

US allows 'game-changer' saliva-based Covid test

Rediff.com16 Aug 2020

The new test it will enable rapid testing amongst more people easily.

Nestle India did not opt for re-test, instead burnt Maggi: FDA

Nestle India did not opt for re-test, instead burnt Maggi: FDA

Rediff.com29 Jul 2015

Maharashtra's Food and Drugs Administration on Wednesday argued in the Bombay High Court that Nestle India.

Ranbaxy brand may fade away as Sun takes charge

Ranbaxy brand may fade away as Sun takes charge

Rediff.com10 Dec 2014

The joint entity will have a market share of nine per cent in India. Analysts tracking the company said one of the key outcomes of the merger would be to create a single brand entity of Sun and the Ranbaxy brand would eventually dissolve.

Markets end on a weak note dragged by pharma shares

Markets end on a weak note dragged by pharma shares

Rediff.com29 Mar 2016

Top 5 losers include Lupin, Cipla, Sun Pharma, Dr Reddy's Lab and GAIL down 1.6%-11%.

US FDA India head quits; regulator goes for rejig

US FDA India head quits; regulator goes for rejig

Rediff.com21 Jul 2014

Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.

Richest self-made woman in America is now the poorest!

Richest self-made woman in America is now the poorest!

Rediff.com2 Jun 2016

Elizabeth Holmes founded Theranos in 2003 and it promised ground-breaking methods that would allow quick results for a wide range of tests with just one drop of blood.

Nifty ends above 7,800 led by financial shares, metals; Oil sinks to 11-year low

Nifty ends above 7,800 led by financial shares, metals; Oil sinks to 11-year low

Rediff.com21 Dec 2015

The S&P BSE Sensex surged 217 points to end at 25,736.

1 held guilty of raping, killing British teen Scarlett Keeling

1 held guilty of raping, killing British teen Scarlett Keeling

Rediff.com17 Jul 2019

The Goa Children's Court had acquitted both last year.

We will regain confidence of the US FDA: Dilip Shanghvi

We will regain confidence of the US FDA: Dilip Shanghvi

Rediff.com26 Mar 2015

'The focus for value creation will be on all business segments.'

Russia sentences US basketball star Griner to 9 years in jail

Russia sentences US basketball star Griner to 9 years in jail

Rediff.com4 Aug 2022

A Russian court sentenced US basketball star Brittney Griner to nine years in prison on Thursday after finding her guilty of deliberately bringing cannabis-infused vape cartridges into Russia, a ruling that President Joe Biden called "unacceptable."

India likely to have Covid vaccine in new year: DCGI

India likely to have Covid vaccine in new year: DCGI

Rediff.com31 Dec 2020

The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.